LTRN - Lantern Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LTRN is currently covered by 1 analysts with an average price target of $10.81. This is a potential upside of $6 (124.74%) from yesterday's end of day stock price of $4.81.

Lantern Pharma's activity chart (see below) currently has 0 price targets and 8 ratings on display. The stock rating distribution of LTRN is 83.33% BUY and 16.67% HOLD.

Stock Analyst Price Targets - Review

Highest price target for LTRN is $5, Lowest price target is $4, average price target is $10.81.

Most recent stock forecast was given by MICHAEL KING from HCWAINWRIGHT on 10-Aug-2023. First documented stock forecast 07-Oct-2021.

Best performing analysts who are covering LTRN - Lantern Pharma:

Michael King

Currently out of the existing stock ratings of LTRN, 5 are a BUY (83.33%), 1 are a HOLD (16.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$11

$5.93 (116.96%)

$11

1 years 6 months 2 days ago
(10-Aug-2023)

0/5 (0%)

$6 (120.00%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LTRN (Lantern Pharma) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on LTRN (Lantern Pharma) with a proven track record?

MICHAEL KING

Which analyst has the most public recommendations on LTRN (Lantern Pharma)?

Michael King has 5 price targets and 4 ratings on LTRN

Which analyst is the currently most bullish on LTRN (Lantern Pharma)?

Michael King with highest potential upside - $5.93

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?